Evidence map›Paper›PMID 36154666›Full record

Trial reportMicrobiology spectrum2022

Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients.

Ilke De Boeck, Eline Cauwenberghs, Irina Spacova, Thies Gehrmann, Tom Eilers, Lize Delanghe, Stijn Wittouck, Peter A Bron, Tim Henkens, Imane Gamgami and 13 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025
    Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Effect of nasal carriage ofMicrobiology spectrum · 2024
    Article
  12. Review
  13. Article
  14. The inner elbow skin microbiome containsMicrobiome research reports · 2024
    Article
  15. Observational
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 2 countries.

Ilke De BoeckResearch Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium.
Eline CauwenberghsResearch Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium.
Irina SpacovaResearch Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium.ORCID 0000-0003-0562-7489
Thies GehrmannResearch Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium.
Tom EilersResearch Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium.
Lize DelangheResearch Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium.
Stijn WittouckResearch Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium.ORCID 0000-0003-3913-5677
Peter A BronResearch Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium.
Tim HenkensYun NV, Niel, Belgium.
Imane GamgamiYun NV, Niel, Belgium.
Alix SimonsYun NV, Niel, Belgium.
Ingmar ClaesYun NV, Niel, Belgium.
Joachim MariënVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Kevin K AriënVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Diana BakokimiVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Katherine LoensVaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerpgrid.5284.b, Antwerp, Belgium.
Kevin JacobsVaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerpgrid.5284.b, Antwerp, Belgium.
Margareta IevenVaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerpgrid.5284.b, Antwerp, Belgium.
Patricia Bruijning-VerhagenJulius Centre for Health Sciences and Primary Care, Department of Epidemiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Peter DelputteLaboratory of Microbiology, Parasitology and Hygiene, University of Antwerpgrid.5284.b, Antwerp, Belgium.ORCID 0000-0003-3972-616X
Samuel CoenenFamily Medicine and Population Health (FAMPOP), University of Antwerpgrid.5284.b, Antwerp, Belgium.
Veronique VerhoevenFamily Medicine and Population Health (FAMPOP), University of Antwerpgrid.5284.b, Antwerp, Belgium.
Sarah LebeerResearch Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium.ORCID 0000-0002-9400-6918
University of Antwerp · BENanotechnology Industries Association · BEInstituut voor Tropische Geneeskunde · BEUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary care urgently needs treatments for coronavirus disease 2019 (COVID-19) patients because current options are limited, while these patients who do not require hospitalization encompass more than 90% of the people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we evaluated a throat spray containing three

Indexed as

COVID-19 Drug TreatmentAntiviral AgentsCOVID-19 TestingHumansLactobacillusOral SpraysOutpatientsPandemicsPharynxSARS-CoV-2Treatment OutcomeAntiviral AgentsOral SpraysCOVID-19lactobacillimicrobiomethroat spray

Identifiers

PMID36154666
PMCPMC9604152
OpenAlexW4297239082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.